Pfizer Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | $31.40B | $59.54B | $2.60B |
| FY2017 | $33.54B | $71.31B | $1.34B |
| FY2018 | $32.91B | $63.41B | $1.14B |
| FY2019 | $35.96B | $63.14B | $1.12B |
| FY2020 | $37.13B | $63.24B | $1.79B |
| FY2021 | $36.20B | $77.20B | $1.94B |
| FY2022 | $32.88B | $95.66B | $416.0M |
| FY2023 | $61.54B | $89.01B | $2.85B |
| FY2024 | $57.41B | $88.20B | $1.04B |
| FY2025 | $61.64B | $86.48B | $1.14B |